Literature DB >> 8911630

Changes in soluble CD4 and CD8 proteins in healthy pregnant and postpartum women.

M Watanabe1, Y Iwatani, Y Hidaka, N Mitsuda, N Amino.   

Abstract

PROBLEM: We examined physiological changes in serum levels of soluble CD4 (sCD4) and soluble CD8 (sCD8) during pregnancy and 1-12 months postpartum to study changes in the maternal immune system during and after pregnancy.
METHOD: The serum concentrations of sCD4 and sCD8 were measured by enzyme immunoassay in the sera separated from blood samples withdrawn from healthy women in the 1st, 2nd, and 3rd trimesters of pregnancy and 1, 4, 7, and 10-12 months postpartum (n = 182) and healthy non-pregnant women (n = 25), and in 90 of the women, the changes in sCD4 and sCD8 were compared with changes in the number of peripheral CD4+ and CD8+ cells measured by flow cytometry.
RESULTS: The serum concentration of sCD4 decreased throughout pregnancy, from the first trimester, and recovered gradually after delivery. The serum concentration of sCD8 did not change significantly during or after pregnancy compared to the concentration in the non-pregnant controls, but the concentration 1 month postpartum was significantly higher than that in the 3rd trimester. The number of CD4+ and cd8+ cells decreased during pregnancy but did not change significantly after delivery. Interestingly, the ratio of the serum sCD4 level to the number of CD4+ cells decreased and the ratio of the sCD8 level to the number of CD8+ cells increased in the first and second trimesters of pregnancy, but these ratios were within the normal range from the third trimester of pregnancy to 10-12 months postpartum.
CONCLUSIONS: Decreases in serum sCD4 concentration and in the ratio sCD4/CD4+ cells, and an increase in the ratio sCD8/CD8+ cells may be important factors in the immunological changes that occur during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8911630     DOI: 10.1111/j.1600-0897.1996.tb00167.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  7 in total

1.  Lower concentration of serum soluble CD8 in severe Hashimoto's disease.

Authors:  N Yamamoto; M Watanabe; F Matsuzuka; A Miyauchi; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

2.  Soluble CD4 concentrations predict relapse of post-partum thyroiditis.

Authors:  C Balázs; N R Farid
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

3.  A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women.

Authors:  Renee Heffron; Deborah Donnell; James Kiarie; Helen Rees; Kenneth Ngure; Nelly Mugo; Edwin Were; Connie Celum; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

4.  Trophoblasts promote induction of a regulatory phenotype in B cells that can protect against detrimental T cell-mediated inflammation.

Authors:  Ruth Marian Guzman-Genuino; Tanya Dimova; Yuan You; Paulomi Aldo; John D Hayball; Gil Mor; Kerrilyn R Diener
Journal:  Am J Reprod Immunol       Date:  2019-10-06       Impact factor: 3.886

5.  The effects of CD40- and interleukin (IL-4)-activated CD23+ cells on the production of IL-10 by mononuclear cells in Graves' disease: the role of CD8+ cells.

Authors:  K Uchimura; M Itoh; K Yamamoto; S Imamura; M Makino; T Kato; K Fujiwara; Y Sawai
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

6.  Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries.

Authors:  Kristin M Wall; Wasima Rida; Lisa B Haddad; Anatoli Kamali; Etienne Karita; Shabir Lakhi; William Kilembe; Susan Allen; Mubiana Inambao; Annie H Yang; Mary H Latka; Omu Anzala; Eduard J Sanders; Linda-Gail Bekker; Vinodh A Edward; Matt A Price
Journal:  Epidemiology       Date:  2017-03       Impact factor: 4.822

Review 7.  Hormonal influences on neuroimmune responses in the CNS of females.

Authors:  Nela Monasterio; Edgar Vergara; Teresa Morales
Journal:  Front Integr Neurosci       Date:  2014-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.